Summary
Aflac Incorporated's 2013 10-K report highlights a company heavily reliant on its Japanese operations, which contributed 74% of total revenues and 85% of total assets. The company's net earnings for 2013 were $3.2 billion, or $6.76 per diluted share, showing an increase from the previous year. Despite a challenging economic environment and the negative impact of a weaker yen on reported revenues, Aflac demonstrated resilience, particularly in its core insurance businesses. The company continues to diversify its product offerings in both Japan and the U.S. Aflac Japan focuses on supplemental health and life insurance, with cancer and medical products remaining strong performers, while Aflac U.S. offers similar voluntary insurance policies alongside group products. The company actively manages its investment portfolio, which primarily consists of fixed-income securities, and engages in hedging activities to mitigate currency and interest rate risks. Shareholder returns were supported by share repurchases totaling $800 million and consistent dividend payments.
Financial Highlights
34 data points| Revenue | $23.94B |
| SG&A Expenses | $2.22B |
| Operating Income | $4.40B |
| Interest Expense | $293.00M |
| Net Income | $3.16B |
| EPS (Basic) | $3.40 |
| EPS (Diluted) | $3.38 |
| Shares Outstanding (Basic) | 929.00M |
| Shares Outstanding (Diluted) | 934.82M |
Key Highlights
- 1Japan operations are the primary driver of Aflac's revenue and assets, accounting for 74% and 85% respectively.
- 2Net earnings increased to $3.2 billion in 2013, with diluted EPS of $6.76.
- 3The weaker yen negatively impacted reported revenues, but the company's core insurance businesses demonstrated resilience.
- 4Aflac Japan's sales declined primarily due to a shift in customer focus from insurance products to investment trusts at banks.
- 5Aflac U.S. saw a slight decrease in new annualized premium sales, impacted by economic conditions and healthcare reform uncertainty.
- 6The company repurchased $800 million of its common stock in 2013 and continued its dividend payments.
- 7Investment portfolio remains heavily focused on fixed-income securities, with a significant portion in Japanese government bonds.